TFX Stock: Teleflex Incorporated Stock Price, Analysis & Insights
Get live tfx stock price $124.75, comprehensive Teleflex Incorporated stock analysis, charts, news, and expert forecast. Real-time tfx stock data and investment insights.
Loading chart...
Company Overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Company Information
- CEO
- Liam J. Kelly
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 14100
Contact Information
- Website
- https://www.teleflex.com
- Address
- 550 East Swedesford Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 29.1)
Business Model & Strategy
Teleflex Incorporated operates in the Medical - Instruments & Supplies industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Liam J. Kelly, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Instruments & Supplies model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Teleflex Incorporated competes in the Medical - Instruments & Supplies within the broader Healthcare. With 5.5 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Teleflex Incorporated provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Teleflex Incorporated should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Teleflex Incorporated shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Teleflex Incorporated
- ⚠Investors should consider how Teleflex Incorporated fits within their overall portfolio allocation
Market Cap
5.51B
P/E Ratio
29.08
Beta
0.95
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 5.51B market capitalization
- Trading Volume: 628.90K shares traded today
- Price Range: 52-week range of $108.90 - $203.33
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Teleflex Incorporated
Teleflex Incorporated (TFX) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 5.51B, the company represents a significant player in its market. The stock is currently trading at $124.75 with a positivedaily change of 0.27%.
The company's 14100 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 29.08, beta of 0.95, and 52-week price range from $108.90 to $203.33when evaluating investment opportunities.
Why Invest in Teleflex Incorporated?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Liam J. Kelly
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.